UPTRAVI (SELEXIPAG) HAS BEEN REGISTERED IN THE RUSSIAN FEDERATION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN ADULT PATIENTS
.
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
InterMedservice
2019-12-01
|
Series: | Евразийский Кардиологический Журнал |
Online Access: | https://www.heartj.asia/jour/article/view/352 |